Vishal Sikri - Dec 31, 2022 Form 5 Insider Report for NEOGENOMICS INC (NEO)

Role
President, Pharma Services
Signature
/s/ Ali Olivo, Attorney-in-Fact
Stock symbol
NEO
Transactions as of
Dec 31, 2022
Transactions value $
$1,584
Form type
5
Date filed
2/1/2023, 04:37 PM
Previous filing
Jun 2, 2022
Next filing
May 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Small acquisition under Rule 16a-6 $1.58K +225 +0.15% $7.04 149K Dec 31, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NEO Stock Option (Right to Buy) 319K Dec 31, 2022 Common Stock 319K $8.42 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired pursuant to NeoGenomics's Employee Stock Purchase Plan (ESPP) during the year ended December 31, 2022. The shares were acquired in transactions exempt from Section 16b-3.
F2 On June 1, 2022, Mr. Sikri was granted 193,799 stock options. These options vest ratably over the first two anniversary dates of the grant date.
F3 On June 1, 2022, Mr. Sikri was granted 125,313 stock options. These options vest ratably over the first four anniversary dates of the grant date.